LOCATION:
Events to come
Current Month
december 2022
june 2022
march 2022
Course: “Pre-Clinical and Clinical Safety in Early Development Human Trials”
-
Faculté de Pharmacie
- 5 rue Jean-Baptiste Clément
Event Details
For the first time, the AFPT-CP1 will run a training course in cooperation with EUFEMED, its European Federation, and Paris-Saclay University. Programme: AFPT-LCP1_SAFETY_final version_23Nov2021 If you are interested by the programme, you
more
Event Details
For the first time, the AFPT-CP1 will run a training course in cooperation with EUFEMED, its European Federation, and Paris-Saclay University.
Programme:
AFPT-LCP1_SAFETY_final version_23Nov2021
If you are interested by the programme, you please register:
This training course will take place from 14-18th of March 2022 in the south of Paris (onsite).
It is a 5-day course on ‘Pre-Clinical and Clinical Safety in Early Development Human Trials’ recognized by Paris-Saclay University and EUFEMED, forming part of a diploma.
It follows the European ‘Pharmatrain’ syllabus, and a certification will be requested in the next future.
It is held in English and is intended for people working in the pharmaceutical industry and students who would like to know more on this sensitive topic.
Do not hesitate to speak of this advanced training to you colleagues who could be interested”
Time
14 (Monday) 9 h 00 min - 18 (Friday) 16 h 00 min ECT
Location
Faculté de Pharmacie
5 rue Jean-Baptiste Clément
Organizer
AFPT - Le Club Phase 1
january 2022
25jan17 h 00 min18 h 30 minFree Online Webinar: Multi-specific Monoclonal Antibodies
Event Details
more
Event Details
REGISTRATION LINK :
Intervenants
Pr Hervé Watier : Hervé Watier is Professor of Immunology at the Faculty of Medicine, Tours, France, and Head of the Laboratory of Immunology in the University Hospital of Tours. He started his medical studies in Lille and his scientific training at the Pasteur Institute of Lille in 1989-91 before completing his MD and PhD theses in Tours. Through pharmacogenetic approaches, he discovered the importance of FcγRIIIA-dependent mechanisms in the action of cytolytic monoclonal antibodies in humans in 2002 and he then specialised in the structure-function relationship studies of therapeutic antibodies. He is coordinating the laboratory of excellence (LabEx) “MAbImprove” since 2011 and a regional program dedicated to biopharmaceuticals since 2013.
Dr Thierry WURCH, Sr.Director – Global External Innovation – Ipsen Since March 20, Thierry is External Innovation lead in Oncology at IPSEN. Dr. Wurch completed a Ph.D. in Molecular and Cellular Biology at the University Louis Pasteur (Strasbourg, FR), followed by post-doctoral training at the University of Ghent (BE). Back to France in 1994, he raised a molecular biology laboratory at the Pierre FABRE Research Center in Castres (FR). In 2003, he moved to the Center for Immunology Pierre FABRE where he established a Molecular and Cellular Biology Department dedicated to molecular pharmacology and protein and antibody engineering. In 2011, Thierry went to SERVIER where he successively led the immunotherapy discovery research programs until end 2016 then joined the newly created External Research and Innovation group overseeing global scouting activities in Oncology. Thierry Wurch is member of the Editorial board of MABS Journal (Taylor & Francis), Distinguished Advisor of The Antibody Society, member of the Scientific advisory board of MabDesign and Chair of the IUPHAR-NC Antibody Committee. He is co-author of more than 90 publications.
Time
(Tuesday) 17 h 00 min - 18 h 30 min ECT
Location
ONLINE
Organizer
AFPT - Le Club Phase 1
AFPT-Club Phase 1
French association of the professionals of human and translational pharmacology
34, avenue des Champs-Elysées 75008 Paris 8ème, France
A founding member of
EVENTS
Current Month
january, 2022
25jan17 h 00 min18 h 30 minFree Online Webinar: Multi-specific Monoclonal Antibodies
Event Details
more
Event Details
REGISTRATION LINK :
Intervenants
Pr Hervé Watier : Hervé Watier is Professor of Immunology at the Faculty of Medicine, Tours, France, and Head of the Laboratory of Immunology in the University Hospital of Tours. He started his medical studies in Lille and his scientific training at the Pasteur Institute of Lille in 1989-91 before completing his MD and PhD theses in Tours. Through pharmacogenetic approaches, he discovered the importance of FcγRIIIA-dependent mechanisms in the action of cytolytic monoclonal antibodies in humans in 2002 and he then specialised in the structure-function relationship studies of therapeutic antibodies. He is coordinating the laboratory of excellence (LabEx) “MAbImprove” since 2011 and a regional program dedicated to biopharmaceuticals since 2013.
Dr Thierry WURCH, Sr.Director – Global External Innovation – Ipsen Since March 20, Thierry is External Innovation lead in Oncology at IPSEN. Dr. Wurch completed a Ph.D. in Molecular and Cellular Biology at the University Louis Pasteur (Strasbourg, FR), followed by post-doctoral training at the University of Ghent (BE). Back to France in 1994, he raised a molecular biology laboratory at the Pierre FABRE Research Center in Castres (FR). In 2003, he moved to the Center for Immunology Pierre FABRE where he established a Molecular and Cellular Biology Department dedicated to molecular pharmacology and protein and antibody engineering. In 2011, Thierry went to SERVIER where he successively led the immunotherapy discovery research programs until end 2016 then joined the newly created External Research and Innovation group overseeing global scouting activities in Oncology. Thierry Wurch is member of the Editorial board of MABS Journal (Taylor & Francis), Distinguished Advisor of The Antibody Society, member of the Scientific advisory board of MabDesign and Chair of the IUPHAR-NC Antibody Committee. He is co-author of more than 90 publications.
Time
(Tuesday) 17 h 00 min - 18 h 30 min ECT
Location
ONLINE
Organizer
AFPT - Le Club Phase 1
LATEST NEWS
Free Online Webinar: Multi-specific Monoclonal Antibodies – 25th January 20227 December 2021 - 20 h 31 min- FIRST ANNOUNCEMENT : 18th AFPT – Le Club Phase 1 – Annual Meeting – 16&17 JUNE 2022 – PARIS7 December 2021 - 15 h 16 min
- Course: “Pre-Clinical and Clinical Safety in Early Development Human Trials” 14-18 March 2022 – 5 days in Paris-Saclay University, France7 December 2021 - 15 h 13 min